Skip to main content
. 2021 Dec 6;53(12):1636–1648. doi: 10.1038/s41588-021-00973-1

Fig. 2. Genetic modifier analyses.

Fig. 2

a, Cox proportional HRs for genome-wide significant SNPs (brown, n = 15), PRSs (red, n = 2) and rare variant burden in ALS-risk genes (pink, n = 7) on survival (months) tested in 6,095 patients with ALS. Estimated HRs are displayed with error bars corresponding to 95% CIs. Higher HRs correspond to shorter survival times. b, Effect estimates from a linear regression model of age at onset (years) in 6,095 patients with ALS. Lower effect estimates correspond to a younger age at onset. Effect estimates from linear regression are displayed with error bars corresponding to 95% CIs. The risk-increasing allele for ALS corresponds to the effect allele for both survival and age-at-onset analyses.

Source data